| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |